Figure 1

Figure 1. Location of Kyangwali Refugee Settlement (black box), Uganda, where 2 cases of Crimean-Congo hemorrhagic fever were reported during 2021. Inset shows close-up view of the settlement area, showing locations of...

On April 27, 2021, a 16-year-old girl (patient 1) living in Kyangwali Refugee Settlement, Kikuube district, Uganda (Figure 1), sought care at a local health facility; clinical manifestations were a 2-day history of fever (38.1°C), headache, fatigue, hematemesis, and epistaxis. The patient had no history of recent travel outside the settlement and had stopped schooling because of national COVID-19 restrictions. The patient had been self-medicating for malaria without improvement; upon the onset of hemorrhagic signs, attending clinicians suspected a viral hemorrhagic fever because of the presence of epistaxis and hematemesis and implemented infection prevention and control measures, including patient isolation and use of personal protective equipment. A blood sample was collected and transported to Uganda Virus Research Institute the same day. Results revealed the patient was positive for CCHFV by real-time reverse transcription PCR (rRT-PCR) and had detectable CCHFV IgM and IgG on a US Centers for Disease Control and Prevention in-house ELISA specific to CCHFV (3).

On April 30, 2021, a 13-year-old boy (patient 2) from the same village was seen at the same health facility; symptoms were a 2-day history of fever that progressed into hemoptysis and epistaxis. The patient tested positive for malaria and received malaria treatment the day of symptom onset, but his condition did not improve. A blood sample was transported to Uganda Virus Research Institute and tested positive for CCHFV by rRT-PCR; CCHFV IgM and IgG were detected.

Figure 2

Figure 2. Phylogenetic analysis of all available full-length Crimean-Congo hemorrhagic fever (CCHF) small (A) and medium (B) segments from GenBank. Orange shading indicates sequence from 16-year-old girl in 2022; blue shading indicates...

Both patients were managed clinically with supportive care, including intravenous fluids and paracetamol; they clinically recovered and were discharged. Next-generation sequencing analysis of nucleic acids extracted from a blood sample from patient 1 indicated the circulating virus grouped within the African 2 lineage, closely matching the virus from a case detected in the same area in 2019 (Figures 1, 2). Sequences were deposited into GenBank (accession nos. OL690430–1). Because of low viral load, generating a sequence from patient 2 was not possible.

Both CCHF patients were from the same village, attended the same church, and were refugees of Congolese origin; however, we did not identify any close contact or epidemiologic link suggestive of human-to-human transmission between them. Patient 1 had previously herded 15 goats that were housed in a barn adjacent to the family’s house and had not recently used tick control measures on the goats. Patient 2 lived near the goat pen of a neighbor in the camp. These goats, together with all livestock herds from the refugee settlement, grazed on communal land that was located <1 km away from the homes of the 2 confirmed patients, enabling easy mixing and transmission of pathogens.

We collected blood samples from 52 goats in the communal grazing land, including the 15 goats owned by patient 1’s family, and tested them by CCHFV rRT-PCR and CCHFV IgG ELISA. All 52 goats were rRT-PCR-negative, but 37/52 (71.3%) goats had detectable IgG. We also collected 14 ticks (Rhipicephalus appendiculatus) from the sampled goats; all tested negative for CCHFV by rRT-PCR.

We describe 2 confirmed human CCHF cases in Kyangwali Refugee Settlement in Uganda. Both patients and their family members were rapidly identified and isolated upon seeking care at the health facility, and appropriate infection prevention and control measures were immediately implemented, which likely prevented onward CCHFV transmission. The presence of an isolation facility in the refugee settlement, set up as part of the COVID-19 response, played a key role in rapidly isolating patients. Both patients were given immediate supportive care and clinically recovered; human-to-human transmission of CCHFV was not identified.

In our investigation, 71.3% of sampled goats had detectable CCHFV IgG, indicating previous infection with CCHFV. As reported, the 2 patients were not living together and did not have direct contact with each other. These patients were likely infected through contact with infected body fluids of livestock or bites from infected ticks.

This investigation highlights some opportunities for improvement of viral hemorrhagic fever surveillance. Patient 1 self-treated with antimalarial medication before seeking care, which delayed isolation and increased the risk for CCHFV transmission, highlighting the importance of community education and encouraging health-promoting behaviors. Second, patient 2 initially tested positive for malaria, emphasizing the additional challenge in malaria-endemic countries of misdiagnosing viral infections such as CCHF as malaria. This challenge highlights the need for improved clinician awareness on the potential for malaria co-infections with other highly communicable pathogens such as CCHFV (G. Akurut, unpub. data); these infections cannot be differentiated without diagnostic testing. Improved diagnostic capability for multipathogen detection could also improve early identification and patient outcomes, as well as limiting the potential for transmission.

Both patients sought care after developing hemorrhagic signs, which usually develop late in illness (8). This timing leads to delayed case detection, which could result in community transmission of the infection. Both patients had detectable CCHFV IgM and IgG, further supporting likely infection 7–10 days before diagnosis (9). Although healthcare workers suspected a viral hemorrhagic fever quickly on the basis of hemorrhagic signs, education is needed on early symptoms, which are nonspecific and can be confused with other causes of acute febrile illnesses, such as malaria or typhoid. Early suspicion and detection will reduce community and hospital transmission and improves the likelihood of early supportive care for and recovery of the infected persons.

Both patients were living in close proximity to goats; the livestock were located in the same compound for patient 1 and in a nearby goat pen for patient 2. Both patients reported close interaction with goats by way of grazing and tethering them. This close interaction with livestock increases the chance of zoonotic disease transmission. Livestock act as reservoirs for pathogens such as Rift Valley fever virus, CCHF, tuberculosis, and brucellosis and should be housed separately because they can act as carriers of infections to humans. The presence of ticks on the sampled goats demonstrates limited tick control in the herd. Tickborne diseases affect not only the health of humans but also livestock production. Vector control strategies coupled with improved management practices would improve these challenges, because communal grazing increases risk for pathogen transmission among animals from different herds.

This investigation of 2 confirmed CCHF cases highlights the rapid identification and intervention by healthcare workers and response from the Kikuube District health team and partners, such as the United Nations High Commission for Refugees, Prime Minister’s office, Medical Teams International, to successfully mitigate onward transmission of CCHFV in this vulnerable community. These efforts are particularly notable given the concurrent burden on the healthcare system and associated disease surveillance challenges from the COVID-19 pandemic.